88 related articles for article (PubMed ID: 10516689)
21. [A patient with small-cell carcinoma of the esophagus with synchronous liver metastasis surviving 48 months after surgery].
Nagahama T; Maruyama M; Tokairin Y; Yoshida T; Baba H; Kure N; Ebuchi M
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1655-8. PubMed ID: 11708001
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
[TBL] [Abstract][Full Text] [Related]
23. [Dose intensity of chemotherapy in small-cell lung carcinoma. Review of comparative studies].
Sanz Rubiales A; del Valle Rivero ML; Garavís Vicente M; Rey Castro P; López-Lara Martín F
An Med Interna; 2000 Jul; 17(7):378-85. PubMed ID: 10981338
[TBL] [Abstract][Full Text] [Related]
24. [Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia].
Amann B; Lüdemann C; Ratei R; Schmidt-Lucke JA
Zentralbl Chir; 2009 Aug; 134(4):298-304. PubMed ID: 19688676
[TBL] [Abstract][Full Text] [Related]
25. Autologous bone marrow/stem cell transplantation: initial experience at a north Indian referral centre.
Gupta S; Kumar L; Raju GM; Kochupillai V; Shukla DK
Natl Med J India; 2000; 13(2):61-6. PubMed ID: 10835851
[TBL] [Abstract][Full Text] [Related]
26. Peripheral blood progenitor cell or bone marrow transplantation: controversy remains.
Koca E; Champlin RE
Curr Opin Oncol; 2008 Mar; 20(2):220-6. PubMed ID: 18300773
[TBL] [Abstract][Full Text] [Related]
27. Autologous bone marrow transplantation in neoplasia.
Dicke KA; Vellekoop L; Spitzer G; Zander AR; Schell F; Verma DS
Transplant Proc; 1981 Mar; 13(1 Pt 1):267-9. PubMed ID: 6267751
[No Abstract] [Full Text] [Related]
28. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
[TBL] [Abstract][Full Text] [Related]
29. Successful renal transplantation following prior bone marrow transplantation in pediatric patients.
Thomas SE; Hutchinson RJ; DebRoy M; Magee JC
Pediatr Transplant; 2004 Oct; 8(5):507-12. PubMed ID: 15367289
[TBL] [Abstract][Full Text] [Related]
30. Autologous stem cell transplantation for high-risk Hodgkin's disease: improvement over time and impact of conditioning regimen.
Subirà M; Sureda A; Martino R; García J; Altés A; Canals C; Domingo-Albós A; Brunet S; Sierra J
Haematologica; 2000 Feb; 85(2):167-72. PubMed ID: 10681724
[TBL] [Abstract][Full Text] [Related]
31. Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma.
Martín A; Pérez-Simón JA; Caballero MD; López-Holgado N; Vázquez L; del Cañizo MC; San Miguel JF
Haematologica; 2005 Jan; 90(1):78-85. PubMed ID: 15642673
[TBL] [Abstract][Full Text] [Related]
32. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546
[TBL] [Abstract][Full Text] [Related]
33. Evolving transplant options for multiple myeloma: autologous and nonmyeloablative allogenic.
Gibson J; Ho PJ; Joshua D
Transplant Proc; 2004 Oct; 36(8):2501-3. PubMed ID: 15561295
[TBL] [Abstract][Full Text] [Related]
34. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.
Choong NW; Quevedo JF; Kaur JS
Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264
[TBL] [Abstract][Full Text] [Related]
35. A murine model of antimetabolite-based, submyeloablative conditioning for bone marrow transplantation: biologic insights and potential applications.
Goebel WS; Pech NK; Meyers JL; Srour EF; Yoder MC; Dinauer MC
Exp Hematol; 2004 Dec; 32(12):1255-64. PubMed ID: 15588950
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia.
Kröger N; Zabelina T; Sonnenberg S; Krüger W; Renges H; Stute N; Finkenstein F; Mayer U; Holstein K; Fiedler W; Colberg H; Sonnen R; Kuse R; Braumann D; Metzner B; del Valle F; Erttmann R; Kabisch H; Zander AR
Bone Marrow Transplant; 2000 Oct; 26(7):711-6. PubMed ID: 11042650
[TBL] [Abstract][Full Text] [Related]
37. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
[TBL] [Abstract][Full Text] [Related]
38. [High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].
Jost LM; Honegger HP; Stahel RA
Schweiz Med Wochenschr; 2000 Jan; 130(3):60-9. PubMed ID: 10683881
[TBL] [Abstract][Full Text] [Related]
39. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
[TBL] [Abstract][Full Text] [Related]
40. [Small-cell carcinoma in the esophagus].
Young K; Cebamanos F; Sing Gómez C
Rev Med Panama; 1994 Sep; 19(3):198-202. PubMed ID: 7746905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
